936845-79-3Relevant academic research and scientific papers
THIAZOLE INHIBITORS TARGETING RESISTANT AND KINASE MUTATIONS
-
Page/Page column 39, (2010/11/27)
A compound is provided, having the general structure (A): wherein A is an aryl or heteroaryl group, Y is a hydrophobic linking moiety, and L is a substitutent. The compound (A) can be used for treatment of various angiogenic-associated or hematologic disorders, such as myeloproliferative disorders in patients who do not respond to kinase-inhibition therapy that comprises administering currently used medications.
